Tissue Hemoglobin Monitoring Is Unable to Follow Variations of Arterial Hemoglobin During Transitions From Pulsatile to Constant Flow in Cardiac Surgery
Continuous monitoring of THb cannot accurately track variations of AHb
World's Largest Resource for Cardiovascular Perfusion
Continuous monitoring of THb cannot accurately track variations of AHb
Patients receiving bivalirudin for systemic anticoagulation on venovenous extracorporeal membrane oxygenation experienced a decrease in the number of extracorporeal membrane oxygenation circuit-related thrombotic events as well as a significant decrease in volume of blood products administered.
DO2 is a monitoring tool that has proven its advantages for monitoring under CPB.